These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13132875)

  • 1. Azaserine, a new tumour-inhibitory substance; studies with Crocker mouse sarcoma 180.
    STOCK CC; REILLY HC; BUCKLEY SM; CLARKE DA; RHOADS CP
    Nature; 1954 Jan; 173(4393):71-2. PubMed ID: 13132875
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME FACTORS AFFECTING THE TUMOR-INHIBITORY PROPERTIES OF COMBINATIONS OF AZASERINE AND 6-CHLOROPURINE.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1963 Aug; 12():847-53. PubMed ID: 14071542
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro effects of azaserine on normal and neoplastic tissue; polarographic behavior of azaserine].
    SANTAMARIA L
    Farmaco Sci; 1955; 10(11):897-909. PubMed ID: 13294172
    [No Abstract]   [Full Text] [Related]  

  • 4. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.
    HANSEN HJ; VANDEVOORDE JP; BENNETT KJ; GILES WG; NADLER SB
    J Lab Clin Med; 1964 May; 63():801-18. PubMed ID: 14158063
    [No Abstract]   [Full Text] [Related]  

  • 5. SOME METABOLIC EFFECTS EXERTED BY AZASERINE AND PURINE ANALOGS IN VIVO.
    SARTORELLI AC; UPCHURCH HF; BIEBER AL; BOOTH BA
    Cancer Res; 1964 Aug; 24():1202-9. PubMed ID: 14216152
    [No Abstract]   [Full Text] [Related]  

  • 6. HOST-TUMOR-DRUG RELATIONSHIPS IN EXPERIMENTAL CHEMOTHERAPY SYSTEMS WITH ALLOGENEIC AND XENOGENEIC HOST-TUMOR COMBINATIONS.
    TELLER MN; WOLFF R; WAGSHUL SF
    Cancer Res; 1964 Jan; 24():114-9. PubMed ID: 14106153
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the mouse Crocker sarcoma 180 with phenanthrene derivatives.
    FIELD JB; KLOETZEL MC; COSTA F; BORYCZKA A
    Acta Unio Int Contra Cancrum; 1955; 11(2):139-42. PubMed ID: 13248720
    [No Abstract]   [Full Text] [Related]  

  • 8. THE UPTAKE OF FUANINE, URACIL, LYSINE AND GLYCINE BY ASCITES CELLS PRETREATED WITH AZASERINE AND 6-THIOGUANINE.
    ADAMS DH
    Biochem J; 1963 Nov; 89(2):240-8. PubMed ID: 14084607
    [No Abstract]   [Full Text] [Related]  

  • 9. IV. Effect of O-diazoacetyl-L-serine (azaserine) on growth of various mouse and rat tumors.
    SUGIURA K; STOCK CC
    Proc Soc Exp Biol Med; 1955 Jan; 88(1):127-9. PubMed ID: 14357363
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the Crocker mouse sarcoma 180 by certain ethyleneimine derivatives and related compounds.
    BUCKLEY SM; STOCK CC; CROSSLEY ML; RHOADS CP
    Cancer; 1952 Jan; 5(1):144-52. PubMed ID: 14886909
    [No Abstract]   [Full Text] [Related]  

  • 11. Azaserine, a tumor inhibitory antibiotic.
    STOCK CC; REILLY HC; BUCKLEY SM; CLARKE DA; RHOADS CP
    Acta Unio Int Contra Cancrum; 1955; 11(2):186-93. PubMed ID: 13248727
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():245-50. PubMed ID: 13746610
    [No Abstract]   [Full Text] [Related]  

  • 13. [TUMOUR CHEMOTHERAPY. IX. NITROGEN MUSTARDS OF PHOSPHORAMIDE, PHOSPHORAMIDE ESTER AND THIOESTER].
    JEN YF
    Yao Xue Xue Bao; 1962 Jan; 9():7-12. PubMed ID: 14074957
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract]   [Full Text] [Related]  

  • 15. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
    BOOTH BA; SARTORELLI AC
    Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870
    [No Abstract]   [Full Text] [Related]  

  • 16. [TUMOUR CHEMOTHERAPY. XIII. SOME SCHIFF'S BASES CONTAINING THE NITROGEN MUSTARD GROUPING].
    LI SW; KAO YS
    Yao Xue Xue Bao; 1962 Mar; 9():167-73. PubMed ID: 14073962
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON HETEROTRANSPLANTATION OF TRANSPLANTED TUMORS AFTER DONOR TRANSPLANTATION].
    NOVIKOV DK
    Vopr Onkol; 1964; 10():47-53. PubMed ID: 14201029
    [No Abstract]   [Full Text] [Related]  

  • 18. [Azaserine, new antibiotic and antitumor agent].
    FERRARI F
    Boll Chim Farm; 1956 Mar; 95(3):113-20. PubMed ID: 13315627
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease.
    ELLISON RR; KARNOFSKY DA; STERNBERG SS; MURPHY ML; BURCHENAL JH
    Cancer; 1954 Jul; 7(4):801-14. PubMed ID: 13172694
    [No Abstract]   [Full Text] [Related]  

  • 20. [ANTITUMOR ACTIVITY OF SOME DERIVATIVES OF BIS(BETA-CHLOROETHYL)-AMINOMETHYLAZOBENZENE].
    KRAVCHENKO AI
    Vopr Onkol; 1963; 9():18-22. PubMed ID: 14149559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.